Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

With biotech firms caught in the crosshairs of Trump's tariffs, the levy could prove to be a boon for domestic producers but ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

President Trump raised tariffs on China to 145% which will likely make electronics and toys more expensive. China responded with 125% tariffs on U.S. goods, including pharmaceutical drugs, planes and ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

Photo: Alamy Novartis announced on Thursday that it will invest $23 billion in the U.S. over the next five years. The ...

Republican Sen. Todd Young of Indiana speaks with NPR's Steve Inskeep about a range of China issues, from the administration's trade war with Beijing to China's growing advantage in biotechnology.

President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

Products made here might still depend on materials from overseas. And they might be made on machines needing foreign replacement parts.